114 related articles for article (PubMed ID: 22006999)
1. p53 negatively regulates the hepatoma growth factor HDGF.
Sasaki Y; Negishi H; Idogawa M; Yokota I; Koyama R; Kusano M; Suzuki H; Fujita M; Maruyama R; Toyota M; Saito T; Tokino T
Cancer Res; 2011 Nov; 71(22):7038-47. PubMed ID: 22006999
[TBL] [Abstract][Full Text] [Related]
2. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B
Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
4. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA
Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells.
Zhang A; Long W; Guo Z; Guo Z; Cao BB
Oncol Rep; 2012 Jul; 28(1):62-8. PubMed ID: 22576797
[TBL] [Abstract][Full Text] [Related]
7. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
8. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
Enomoto H; Yoshida K; Kishima Y; Kinoshita T; Yamamoto M; Everett AD; Miyajima A; Nakamura H
Hepatology; 2002 Dec; 36(6):1519-27. PubMed ID: 12447878
[TBL] [Abstract][Full Text] [Related]
10. Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway.
Kung ML; Tsai HE; Hu TH; Kuo HM; Liu LF; Chen SC; Lin PR; Ma YL; Wang EM; Liu GS; Liu JK; Tai MH
Biochem Biophys Res Commun; 2012 Aug; 425(2):169-76. PubMed ID: 22819846
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity.
Abouzied MM; Baader SL; Dietz F; Kappler J; Gieselmann V; Franken S
Biochem J; 2004 Feb; 378(Pt 1):169-76. PubMed ID: 14572309
[TBL] [Abstract][Full Text] [Related]
12. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour.
Yang Y; Zhen T; Zhang F; Dai S; Kang L; Liang Y; Xue L; Han A
J Clin Pathol; 2014 Mar; 67(3):235-42. PubMed ID: 24072730
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor p53 represses transcription of RECQ4 helicase.
Sengupta S; Shimamoto A; Koshiji M; Pedeux R; Rusin M; Spillare EA; Shen JC; Huang LE; Lindor NM; Furuichi Y; Harris CC
Oncogene; 2005 Mar; 24(10):1738-48. PubMed ID: 15674334
[TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.
Thirant C; Galan-Moya EM; Dubois LG; Pinte S; Chafey P; Broussard C; Varlet P; Devaux B; Soncin F; Gavard J; Junier MP; Chneiweiss H
Stem Cells; 2012 May; 30(5):845-53. PubMed ID: 22331796
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma-derived growth factor, a new trophic factor for motor neurons, is up-regulated in the spinal cord of PQBP-1 transgenic mice before onset of degeneration.
Marubuchi S; Okuda T; Tagawa K; Enokido Y; Horiuchi D; Shimokawa R; Tamura T; Qi ML; Eishi Y; Watabe K; Shibata M; Nakagawa M; Okazawa H
J Neurochem; 2006 Oct; 99(1):70-83. PubMed ID: 16987236
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate specific antigen (PSA) is negatively regulated by p53.
Gurova KV; Roklin OW; Krivokrysenko VI; Chumakov PM; Cohen MB; Feinstein E; Gudkov AV
Oncogene; 2002 Jan; 21(1):153-7. PubMed ID: 11791186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
